The CDK2 inhibitor INCB123667 showed positive efficacy and safety signals in platinum-resistant/refractory ovarian cancer.

Maya Ortiz of North Reading is organizing “Trotting In Teal,” an awareness/fundraising event for ovarian cancer that will be ...

Glucagon-like peptide-1 (GLP-1) receptor agonists significantly enhance overall survival in patients with ovarian cancer, ...

Delta passengers were stranded on a tiny island in the middle of the Atlantic for 29 hours after midair engine trouble ...

Genetic testing revealed that she was positive for BRCA1, a genetic mutation that increases one’s risk of breast and ovarian ...

Ovarian cancer often goes undetected until advanced stages. Emerging tools like liquid biopsies and AI offer hope, but ...

New research reveals PD-L1 expression enhances survival in advanced ovarian cancer, linking it to homologous recombination ...

A groundbreaking new therapy for ovarian cancer is being trialled on a Brisbane woman, in an Australian-first, which aims to ...

A doctor has shared five symptoms of a type of cancer she says 'everyone' should know, as it can be 'difficult to detect' if ...

Overall, 35% of patients' records had evidence of comprehensive genomic profiling (CGP). The rate increased modestly from 32% at the beginning of the study period to 39% at the end, reported Stacey ...

Fat tissue secretes hormones known as adipokines. Patients with obesity have a larger amount of leptin than a normal ...

Disease-free and overall survival were comparable between paclitaxel- and cisplatin-based heated chemotherapy regimens in ...